☆ 4.8 Article

Synthesis of Adagrasib (MRTX849), a Covalent KRASG12C Inhibitor Drug for the Treatment of Cancer

ORGANIC LETTERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)

Sai-Hong Ignatius Ou et al.

Summary: This study reported the results of a clinical trial using adagrasib to treat non-small-cell lung cancer, colorectal cancer, and other solid tumors with the KRAS(G12C) mutation. The recommended phase II dose was identified as 600 mg twice a day, and it demonstrated good tolerability and antitumor activity.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Chemistry, Applied

Development of a Practical and Greener Process for the Dual Leucine Zipper Kinase Inhibitor GDC-0134 Comprising Two SNAr Reactions, Oxidation and Suzuki Coupling

Fabienne Hoffmann-Emery et al.

Summary: A sustainable second-generation process for GDC-0134 was developed to meet the safety and greenness requirements of supplying pivotal clinical studies. The process involved the discovery of alternative solvents and improved reaction conditions, resulting in a significant reduction in process mass intensity and the successful production of a large amount of GDC-0134.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2022)

添加到收藏夹

Article Chemistry, Applied

Sulfone Displacement Approach for Large-Scale Synthesis of 4-Chloro-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine

Chaomin Li et al.

Summary: The paper discusses the route evaluation, process development, and large-scale manufacturing of 4-chloro-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine (1). The improved route involves two linear chemical steps and allows for efficient production of the target compound. Density functional theory (DFT) calculations were performed to enhance the understanding of reactivity and selectivity.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2022)

添加到收藏夹

Review Oncology

Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

Anne-Laure Desage et al.

Summary: This article discusses new therapeutic strategies targeting KRAS G12C and promising approaches of combined therapy to overcome acquired resistance, highlighting their importance in non-small cell lung cancer.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Chemistry, Organic

A Nucleophilic Deprotection of Carbamate Mediated by 2-Mercaptoethanol

Thomas Scattolin et al.

Summary: Carbamates, commonly used to protect amines, can be easily deprotected using 2-mercaptoethanol and potassium phosphate tribasic in N,N-dimethylacetamide. This nucleophilic deprotection method is superior to traditional methods for substrates with sensitive functionalities.

ORGANIC LETTERS (2022)

添加到收藏夹

Article Medicine, General & Internal

Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation

Pasi A. Jaenne et al.

Summary: Adagrasib demonstrated clinical efficacy without new safety signals in previously treated KRAS(G12C)-mutated NSCLC patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Chemistry, Applied

Kilo-Scale Electrochemical Oxidation of a Thioether to a Sulfone: A Workflow for Scaling up Electrosynthesis

Cecilia Bottecchia et al.

Summary: Organic electrosynthesis is a rapidly growing field that provides powerful methods for assembling targeted compounds in organic synthesis. However, concerns about scalability have limited its implementation in the pharmaceutical industry. In this study, a workflow was developed to successfully scale up an organic electrosynthetic method from milligram to kilogram scale. By using online flow nuclear magnetic resonance spectroscopy, offline ion chromatography, cyclic voltammetry, and density functional theory calculations, the reaction mechanism and side reactions were elucidated.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2022)

添加到收藏夹

News Item Multidisciplinary Sciences

Cancer drugs are closing in on some of the deadliest mutations

Heidi Ledford

Summary: Scientists are aiming to save lives by targeting the mutated KRAS protein with a batch of new compounds, despite it being previously considered 'undruggable'.

NATURE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

KRAS mutation: from undruggable to druggable in cancer

Lamei Huang et al.

Summary: This review provides the latest understanding of fundamental aspects of KRAS, the relationship between KRAS mutations and tumor immune evasion, and new progress in targeting KRAS, particularly KRAS (G12C). The possible mechanisms of resistance to KRAS (G12C) inhibitors and potential combination therapies are also summarized, aiming to offer the best personalized treatment regimen with KRAS (G12C) inhibitors and achieve truly precise treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Chemistry, Inorganic & Nuclear

Selected methods for the synthesis of sulfoxides and sulfones with emphasis on oxidative protocols

Sina Matavos-Aramyan et al.

PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS (2020)

添加到收藏夹

Article Oncology

The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Jill Hallin et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer

Jay B. Fell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

An environmentally benign and selective electrochemical oxidation of sulfides and thiols in a continuous-flow microreactor

Gabriele Laudadio et al.

GREEN CHEMISTRY (2017)

添加到收藏夹

Review Chemistry, Organic

Recent Advances in the Synthesis of Sulfones

Nai-Wei Liu et al.

SYNTHESIS-STUTTGART (2016)

添加到收藏夹

Article Chemistry, Organic

One-Step Synthesis of 2-Chloropyrimidin-4-ol Derivatives: An Unusual Reactivity of Thiophosgene

Michael Callingham et al.

ORGANIC LETTERS (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Highly atom-economic, catalyst- and solvent-free oxidation of sulfides into sulfones using 30% aqueous H2O2

Marjan Jereb

GREEN CHEMISTRY (2012)

添加到收藏夹

Article Chemistry, Applied

Process Safety Evaluation of a Tungsten-Catalyzed Hydrogen Peroxide Epoxidation Resulting In a Runaway Laboratory Reaction

Susan Shilcrat

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2011)

添加到收藏夹

Article Chemistry, Applied

Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor

Liang Zhang et al.

Summary: The commercial process for manufacturing sotorasib (AMG 510) focused on improving yield and product quality, reducing side reactions, and optimizing cycle times of crystallization processes. These improvements were crucial for ensuring clinical supply and commercial launch.

ORGANIC PROCESS RESEARCH & DEVELOPMENT

添加到收藏夹

© Peeref 2019-2024. All rights reserved.